US 12,272,061 B2
Image analysis method, apparatus, non-transitory computer readable medium, and deep learning algorithm generation method
Akimichi Ohsaka, Tokyo (JP); Yoko Tabe, Tokyo (JP); and Konobu Kimura, Kobe (JP)
Assigned to JUNTENDO EDUCATIONAL FOUNDATION, Tokyo (JP); and SYSMEX CORPORATION, Kobe (JP)
Filed by JUNTENDO EDUCATIONAL FOUNDATION, Tokyo (JP); and SYSMEX CORPORATION, Kobe (JP)
Filed on Oct. 18, 2023, as Appl. No. 18/489,475.
Application 18/489,475 is a continuation of application No. 17/398,850, filed on Aug. 10, 2021, granted, now 11,830,188.
Application 17/398,850 is a continuation of application No. 16/406,523, filed on May 8, 2019, granted, now 11,093,729, issued on Aug. 17, 2021.
Claims priority of application No. 2018-091776 (JP), filed on May 10, 2018.
Prior Publication US 2024/0062377 A1, Feb. 22, 2024
Int. Cl. G06T 7/12 (2017.01); G06F 18/214 (2023.01); G06F 18/2431 (2023.01); G06N 3/08 (2023.01); G06T 7/00 (2017.01); G06V 10/44 (2022.01); G06V 10/764 (2022.01); G06V 10/82 (2022.01); G06V 20/69 (2022.01)
CPC G06T 7/0012 (2013.01) [G06F 18/2148 (2023.01); G06F 18/2431 (2023.01); G06N 3/08 (2013.01); G06V 10/449 (2022.01); G06V 10/764 (2022.01); G06V 10/82 (2022.01); G06V 20/698 (2022.01); G06T 2207/20076 (2013.01); G06T 2207/20081 (2013.01); G06T 2207/20084 (2013.01)] 20 Claims
OG exemplary drawing
 
1. An image analysis method comprising:
inputting analysis data into a deep learning algorithm having a neural network structure, the analysis data being generated from an image of an analysis target cell and including information regarding the analysis target cell; and
classifying, by use of the deep learning algorithm, the analysis target cell into at least one of categories of a blood cell, wherein
the categories include morphological features of white blood cells observed in myelodysplastic syndromes, wherein
the morphological features of white blood cells include at least morphological nucleus abnormality, presence of vacuole, granule morphological abnormality, granule distribution abnormality, presence of abnormal granule, cell size abnormality, presence of inclusion body, or bare nucleus.